28 February 2005
Biotech Buyout Binge Continues
For the second week in a row, buyout rumors and merger speculation sent a number of biotech and specialty pharmaceutical shares higher.
Biotech Blog
For the second week in a row, buyout rumors and merger speculation sent a number of biotech and specialty pharmaceutical shares higher.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology. He is also founder of DrugPatentWatch.com, and has a long history in biotechnology media. read more…
